The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, L.-P.
Right arrow Articles by McMichael, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, L.-P.
Right arrow Articles by McMichael, A. J.
The Journal of Immunology, 2004, 172: 7350-7358.
Copyright © 2004 by The American Association of Immunologists

CD4CD8{alpha}{alpha} Subset of CD1d-Restricted NKT Cells Controls T Cell Expansion1

Ling-Pei Ho2,*,{dagger}, Britta C. Urban*, Louise Jones*, Graham S. Ogg* and Andrew J. McMichael*

* Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, and {dagger} Oxford Center for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom

V{alpha}24 invariant (V{alpha}24i) CD1d-restricted NKT cells are widely regarded to have immune regulatory properties. They are known to have a role in preventing autoimmune diseases and are involved in optimally mounted immune responses to pathogens and tumor cells. We were interested in understanding how these cells provide protection in autoimmune diseases. We first observed, using EBV/MHC I tetrameric complexes, that expansion of Ag-specific cells in human PBMCs was reduced when CD1d-restricted NKT cells were concomitantly activated. This was accompanied by an increase in a CD4CD8{alpha}{alpha}+ subset of V{alpha}24i NKT cells. To delineate if a specific subset of NKT cells was responsible for this effect, we generated different subsets of human CD4 and CD4+ V{alpha}24i NKT clones and demonstrate that a CD4CD8{alpha}{alpha}+ subset with highly efficient cytolytic ability was unique among the clones in being able to suppress the proliferation and expansion of activated T cells in vitro. Activated clones were able to kill CD1d-bearing dendritic or target cells. We suggest that one mechanism by which CD1d-restricted NKT cells can exert a regulatory role is by containing the proliferation of activated T cells, possibly through timely lysis of APCs or activated T cells bearing CD1d.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Moreno, J. W. Molling, S. von Mensdorff-Pouilly, R. H. M. Verheijen, E. Hooijberg, D. Kramer, A. W. Reurs, A. J. M. van den Eertwegh, B. M. E. von Blomberg, R. J. Scheper, et al.
IFN-{gamma}-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses
J. Immunol., August 15, 2008; 181(4): 2446 - 2454.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. D. Hazlett, Q. Li, J. Liu, S. McClellan, W. Du, and R. P. Barrett
NKT Cells Are Critical to Initiate an Inflammatory Response after Pseudomonas aeruginosa Ocular Infection in Susceptible Mice
J. Immunol., July 15, 2007; 179(2): 1138 - 1146.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L.-P. Ho
Natural Killer T Cells in Asthma -- Toward Increased Understanding
N. Engl. J. Med., April 5, 2007; 356(14): 1466 - 1468.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Coppieters, P. Dewint, K. Van Beneden, P. Jacques, S. Seeuws, G. Verbruggen, D. Deforce, and D. Elewaut
NKT cells: manipulable managers of joint inflammation
Rheumatology, April 1, 2007; 46(4): 565 - 571.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Mitsuo, S. Morimoto, Y. Nakiri, J. Suzuki, H. Kaneko, Y. Tokano, H. Tsuda, Y. Takasaki, and H. Hashimoto
Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases
Rheumatology, December 1, 2006; 45(12): 1477 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Terabe, C. Khanna, S. Bose, F. Melchionda, A. Mendoza, C. L. Mackall, L. J. Helman, and J. A. Berzofsky
CD1d-Restricted Natural Killer T Cells Can Down-regulate Tumor Immunosurveillance Independent of Interleukin-4 Receptor-Signal Transducer and Activator of Transcription 6 or Transforming Growth Factor-{beta}.
Cancer Res., April 1, 2006; 66(7): 3869 - 3875.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. J. Ragin, N. Sahu, and A. August
Differential Regulation of Cytokine Production by CD1d-Restricted NKT Cells in Response to Superantigen Staphylococcal Enterotoxin B Exposure
Infect. Immun., January 1, 2006; 74(1): 282 - 288.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. H. Chang, K. Osman, J. Connolly, A. Kukreja, J. Krasovsky, M. Pack, A. Hutchinson, M. Geller, N. Liu, R. Annable, et al.
Sustained expansion of NKT cells and antigen-specific T cells after injection of {alpha}-galactosyl-ceramide loaded mature dendritic cells in cancer patients
J. Exp. Med., May 2, 2005; 201(9): 1503 - 1517.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Chung, A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan
Cutting Edge: Signaling Lymphocytic Activation Molecule-Associated Protein Controls NKT Cell Functions
J. Immunol., March 15, 2005; 174(6): 3153 - 3157.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.